Baker McKenzie advise Lundbeck in $2.6B Longboard Pharmaceuticals acquisition
Baker McKenzie advise Lundbeck in $2.6B Longboard Pharmaceuticals acquisition. Baker McKenzie Leads Lundbeck’s $2.6B Deal For US Pharma Longboard According to the agreement, Lundbeck plans to initiate a tender offer for all outstanding shares of Longboard’s common stock, offering Longboard shareholders a cash payment of USD 60.00 per share. This transaction is estimated to be […]